إعلان
إعلان
FENC
Fennec Pharmaceuticals Inc. Common Stock
7.75
USDبرعاية
+0.17
+2.18%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
7.77
+0.02
+0.32%
تقارير أرباح FENC
النسبة الإيجابية المفاجئة
FENC تفوق 15 من 33 آخر التقديرات.
45%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$14.03M
/$0.04
التغير الضمني من Q3 25 (Revenue/ EPS)
+12.56%
/-300.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+77.00%
/-166.67%
Fennec Pharmaceuticals Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, FENC reported earnings of -0.02 USD per share (EPS) for Q3 25, beating the estimate of -0.02 USD, resulting in a 8.26% surprise. Revenue reached 12.46 مليون, compared to an expected 11.48 مليون, with a 8.54% difference. The market reacted with a +2.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of 0.04 USD, with revenue projected to reach 14.03 مليون USD, implying an نقصان of -300.00% EPS, and زيادة of 12.56% in Revenue from the last quarter.
الأسئلة الشائعة
What were Fennec Pharmaceuticals Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fennec Pharmaceuticals Inc. Common Stock reported EPS of -$0.02, beating estimates by 8.26%, and revenue of $12.46M, 8.54% above expectations.
How did the market react to Fennec Pharmaceuticals Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2.21%, changed from $7.69 before the earnings release to $7.86 the day after.
When is Fennec Pharmaceuticals Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Fennec Pharmaceuticals Inc. Common Stock's next earnings report?
Based on 7
المحللين, Fennec Pharmaceuticals Inc. Common Stock is expected to report EPS of $0.04 and revenue of $14.03M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان